COMMUNIQUÉS West-GlobeNewswire

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
EMERYVILLE, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
BOTHELL, Wash., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/02/2019
BOSTON, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today announced that on [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/02/2019
SANTA BARBARA, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on January 31, 2019, the Compensation Committee of [...]
Tabula Rasa HealthCare’s Subsidiary Completes Implementation of Precision Dosing Software for One of the Nation’s Leading Healthcare Systems
01/02/2019
MOORESTOWN, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced its newly acquired [...]
Pixium Vision: Information on total number of voting rights and shares composing the share capital as at January 31st, 2019
01/02/2019
Information on total number of voting rights and shares composing the share capital as at January 31 st , 2019 Paris, February 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company [...]
Pixium Vision : Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2019
01/02/2019
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2019 Paris, le 1 er février 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique [...]
Nicox: Number of voting rights as of january 31, 2019
01/02/2019
Nicox SA Société anonyme with a registered capital of € 29,718,920 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On February 1, 2019, MONTHLY PUBLICATION OF THE [...]
Nicox : Nombre de droits de vote au 31 janvier 2019
01/02/2019
Nicox SA Société anonyme au capital de 29 718 920 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1er février 2019, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Title21 Health Solutions Is a ‘Great Place to Work’®
01/02/2019
Cellular Therapy and Enterprise Quality Management Software Company is Recognized as Having an Outstanding Culture by Great Place to Work® PLEASANTON, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Title21 Health Solutions [...]
BioAegis Therapeutics Announces Publication in “Clinical Infectious Diseases” Linking Depleted Plasma Gelsolin Concentrations at Admission to Severe Pneumonia Outcomes in CDC-Sponsored “Etiology of Pneumonia in the Community (EPIC)” Study
01/02/2019
MORRISTOWN, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced the publication of a paper in Clinical Infectious Disease—a journal of the Infectious Disease Society of America entitled, Low [...]
Active Biotech has received an indicative bid for the property in Lund - the Board is positive
01/02/2019
As previously reported, Active Biotech's property Forskaren 1 in Lund has been on sale for a period of time. Active Biotech has now received an indicative, non-binding bid for the property, amounting to SEK 275 million [...]
Typenex® Medical Awarded National MAGNET GROUP Contract
01/02/2019
Gives Members Access to Full Portfolio of Patient Identification Products CHICAGO, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Typenex Medical , an industry leader in Healthcare, announced it has been awarded the MAGNET GROUP GPO [...]
Outlook Therapeutics Closes Final Tranche of $20 Million Private Placement
01/02/2019
CRANBURY, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”) today announced that it closed on the final tranche (of four) of its $20.0 million private placement of common [...]
Former Assistant U.S. Attorney Joins Phoenix Life Sciences International as Company’s Vice President of Regulatory Affairs
01/02/2019
DENVER, CO, Feb. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that [...]
HMS to Report Fourth Quarter 2018 Financial Results on February 22, 2019
01/02/2019
IRVING, Texas, Feb. 01, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the fourth quarter and year ended December 31, 2018 at 7:30 am CT / 8 [...]
Milestone Scientific Announces Pricing of $2.0 Million Offering of Common Stock and Warrants
01/02/2019
LIVINGSTON, N.J., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the [...]
Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on Friday, March 1, 2019
01/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results [...]
OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer
01/02/2019
MIAMI, Feb. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s point-of-care Sangia Total Prostate Specific Antigen ( [...]

Pages